Ozguroglu, M. Et Al. 2006. Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC). 31st Congress of the European-Society-for-Medical-Oncology , (İstanbul, Turkey), 225.

Ozguroglu, M., Evrensel, T., Er, O., TURNA, Z. H., Yanmaz, T., Yildiz, O., ... Mandel, N.(2006). Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC) . 31st Congress of the European-Society-for-Medical-Oncology (pp.225). İstanbul, Turkey

Ozguroglu, Mustafa Et Al. "Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)," 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 2006

Ozguroglu, Mustafa Et Al. "Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, pp.225, 2006

Ozguroglu, M. Et Al. (2006) . "Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, p.225.

@conferencepaper{conferencepaper, author={Mustafa Ozguroglu Et Al. }, title={Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)}, congress name={31st Congress of the European-Society-for-Medical-Oncology}, city={İstanbul}, country={Turkey}, year={2006}, pages={225} }